These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Novel difluoromethyl-containing 1-((4-methoxy-3-(piperazin-1-yl)phenyl)sulfonyl)-1H-indole scaffold as potent 5-HT6R antagonists: Design, synthesis, biological evaluation, and early in vivo cognition-enhancing studies. Yi C, Xue Y, Chen K, Wang T, Yu J, Wang Z, Jin C. Bioorg Med Chem; 2022 Sep 15; 70():116917. PubMed ID: 35839536 [Abstract] [Full Text] [Related]
23. Epiminocyclohepta[b]indole analogs as 5-HT6 antagonists. Henderson AJ, Guzzo PR, Ghosh A, Kaur J, Koo JM, Nacro K, Panduga S, Pathak R, Shimpukade B, Tan V, Xiang K, Wierschke JD, Isherwood ML. Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1494-8. PubMed ID: 22290076 [Abstract] [Full Text] [Related]
24. Idalopirdine as a treatment for Alzheimer's disease. Galimberti D, Scarpini E. Expert Opin Investig Drugs; 2015 Feb 15; 24(7):981-7. PubMed ID: 26022777 [Abstract] [Full Text] [Related]
30. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies. Sagnes C, Fournet G, Satala G, Bojarski AJ, Joseph B. Eur J Med Chem; 2014 Mar 21; 75():159-68. PubMed ID: 24531229 [Abstract] [Full Text] [Related]
31. The 5-HT6 receptor antagonist idalopirdine potentiates the effects of acetylcholinesterase inhibition on neuronal network oscillations and extracellular acetylcholine levels in the rat dorsal hippocampus. Herrik KF, Mørk A, Richard N, Bundgaard C, Bastlund JF, de Jong IEM. Neuropharmacology; 2016 Aug 21; 107():351-363. PubMed ID: 27039041 [Abstract] [Full Text] [Related]
32. Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain. Borsini F, Bordi F, Poggi A, Di Matteo V. J Psychopharmacol; 2015 Jul 21; 29(7):802-11. PubMed ID: 25735994 [Abstract] [Full Text] [Related]
36. Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease. Wicke K, Haupt A, Bespalov A. Expert Opin Investig Drugs; 2015 Oct 15; 24(12):1515-28. PubMed ID: 26548316 [Abstract] [Full Text] [Related]
37. 5-HT1A and 5-HT2A receptor affinity and functional profile of some N-[3-(4-aryl-1-piperazinyl)propyl] derivatives of indolin-2(1H)-one, quinolin-2(1 H)-one and isoquinolin-1(2H)-one. Part 30: Structure-activity relationship studies of CNS agents. Mokrosz MJ, Mokrosz JL, Duszyńska B, Dereń-Wesołek A, Kłodzińska A, Kowalski P, Charakchieva-Minol S, Tatarczyńska E, Kowalska T, Majka Z, Chojnacka-Wójcik E, Misztal S. Pharmazie; 1997 Jun 15; 52(6):423-8. PubMed ID: 9260266 [Abstract] [Full Text] [Related]